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Abstract
Background: Although intravitreal injection of bevacizumab (IVB) is effective for macular edema in patients with
branch retinal vein occlusion (BRVO), the changes of retinal hemodynamics remain unclear. We investigated retinal
hemodynamic changes in BRVO patients after IVB by performing laser speckle flowgraphy (LSFG).
Methods: In 35 BRVO patients with macular edema, the relative flow volume (RFV) of the retinal artery and vein
passing through the optic disc was measured in both the occluded and non-occluded regions of the retina before
IVB and 1 month after IVB by LSFG. The ischemic region of retina was measured with the Scion Image program and
the severity of retinal ischemia was assessed by dividing the non-perfused area by the disc area.
Results: Macular edema improved significantly by 1 month after IVB. The venous RFV ratio showed a significant
increase in the non-occluded region at 1 month after IVB. There was a significant negative correlation between the
venous RFV ratio and the severity of retinal ischemia in the occluded region. On the other hand, arterial RFV ratio
showed no significant change after IVB in either the occluded or non-occluded region. In addition, there was no
significant correlation between the arterial RFV ratio and the severity of retinal ischemia in either the occluded or
non-occluded region.
Conclusions: These results suggest that an increase of retinal venous outflow after IVB may possibly influence the
resolution of macular edema and that the response of venous outflow after IVB depends on the severity of retinal
ischemia in the occluded region.
Background
Branch retinal vein occlusion (BRVO) is a very common
retinal vascular condition in patients with lifestyle-related
diseases such as hypertension and arteriosclerosis. Because
retinal arterioles and venules have a common adventitia at
arteriovenous crossings, the vein walls can be compressed
by arteriosclerotic changes. Luminal narrowing leads to
disturbance of laminar blood flow and endothelial damage
is caused by shear stress, after which thrombus formation
leads to BRVO [1]. In the acute phase of BRVO, pressure
increases in the capillaries and venules affected by ob-
struction, leading to breakdown of the blood-retinal
barrier and leakage of blood components. The main
cause of visual impairment in BRVO patients is macular
edema. Thus, understanding the retinal hemodynamic ab-
normalities that underlie the pathogenesis of BRVO is of
critical importance.
A multicenter study [2] has shown that intravitreal
injection of bevacizumab (IVB) is effective for macular
edema in BRVO patients, but the retinal hemodynamic
changes remain unclear. Laser speckle flowgraphy (LSFG)
is a noninvasive technique based on the laser speckle
phenomenon that allows simultaneous assessment of blood
flow in the vessels of the optic nerve head, choroid, and
retina [3]. The relative flow volume (RFV) obtained with
LSFG was recently reported to be an accurate and reliable
index of blood flow volume in the retinal vessels [4]. This* Correspondence: noma-hide@umin.ac.jpDepartment of Ophthalmology, Hachioji Medical Center, Tokyo Medical
University, 1163, Tatemachi, Hachioji, Tokyo 193-0998, Japan
© 2016 Noma et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Noma et al. BMC Ophthalmology  (2016) 16:61 
DOI 10.1186/s12886-016-0239-8
index could potentially provide an accurate assessment of
retinal blood flow in the superficial layer of the retina [4].
In the present study, changes of retinal hemodynamics
after IVB were investigated in BRVO patients with
macular edema by LSFG. RFV was measured separately
for retinal arteries and veins in the occluded and non-
occluded regions of the retina.
Methods
Subjects
This study was conducted at the Department of Oph-
thalmology of Tokyo Medical University and approval
was obtained from the University Ethics Committee. The
procedures of the study conformed to the tenets of the
Declaration of Helsinki and all patients gave written in-
formed consent before enrollment. Thirty-five patients with
BRVO (35 eyes) who were scheduled to undergo intravit-
real injection of bevacizumab (1.25 mg in 0.05 ml, Avascin;
Genentech and Hoffmann La Roche, Basel, Switzerland)
were studied between January and August 2013. Criteria
for receiving IVB were macular edema involving the fovea
(central macular thickness (CMT) > 300 μm), and best-
corrected visual acuity (BCVA) < 20/30. There were 18 men
and 17 women aged 67.6 ± 11.0 years (mean ± SD). The
mean duration of macular edema was 53.3 ± 40.4 days
(range: 15–180 days). Twenty-three of the 35 patients
(66 %) had hypertension and 15 of the 35 patients (43 %)
had hyperlipidemia.
Exclusion criteria were glaucoma, aphakia, rubeosis
iridis, clinically significant cataract, ocular infection, a
history of retinal diseases other than BRVO, laser co-
agulation, refractive error of less than - 6.0 diopters,
and intraocular surgery (including cataract surgery) on
the index eye within 6 months of the scheduled time
for injection of bevacizumab.
Routine examinations
At the initial visit, all patients underwent a complete
ophthalmic examination including decimal BCVA, fluor-
escein angiography (FA) (Digital Retinal Camera CF-1;
Canon, NY, USA) and spectral-domain OCT (Spectralis,
Heidelberg Engineering, Heidelberg, Germany). A masked
grader independently assessed retinal ischemia by examin-
ing the angiograms and measuring the ischemic region of
the retina with the public domain Scion Image program
[5]. On digital fluorescein photographs, the disc area was
outlined with a cursor and then measured, after which the
same was done for the non-perfused area. The severity of
retinal ischemia was assessed as the non-perfused area di-
vided by the disc area. For follow up, BCVA was deter-
mined and OCT was performed at 1 month after IVB.
The CMT was defined as the distance between the inner
limiting membrane and the retinal pigment epithelium
(including any serous retinal detachment), and was
automatically measured by computer software. BCVA was
converted to the logarithm of minimal angle of resolution
(logMAR) scale for statistical analysis.
Laser speckle flowgraphy (LSFG)
LSFG (Softcare, Fukutsu, Japan) has been described in
detail previously [3]. In brief, a fundus camera equipped
with a diode laser (wavelength, 830 nm) and a charge-
coupled device sensor (750 × 360 pixels) are used to ob-
tain images of the pattern of speckle contrast produced
by interference as laser light is scattered by red blood
cells moving through vessels in the ocular fundus. Light
reflected from the tissue produces a speckled pattern on
the plane where the area sensor is focused and reflected
light from moving erythrocytes causes blurring of the
speckle pattern [6].
The mean blur rate (MBR) was calculated from variation
of the blurring as a quantitative index of relative blood
flow velocity expressed in arbitrary units (AU) [4, 7]. Im-
ages were acquired continuously at the rate of 30 frames/
sec over a 4-sec period and then averaged to produce a
composite map of ocular blood flow.
RFV was obtained by manually selecting a region of
interest centered on a retinal vessel. A separate MBR
value was then automatically calculated for the vessel by
subtracting the background choroidal blood flow from
the overall MBR value. Then RFV was determined by in-
tegrating the MBR values in a direction transverse to the
retinal vessel. RFV reflects blood flow volume rather
than flow velocity based on the relation between a trunk
vessel and its branches [4], and it was calculated by
using Cross-Section Ex in the LSFG analyzer software
(version 3.1.6). The RFV of the artery and vein passing
through the optic disc was measured in both the occluded
and non-occluded regions before IVB and 1 month after
IVB (Fig. 1a and b).
The pupil was dilated with 0.5 % tropicamide and
0.5 % phenylephrine hydrochloride 20 min before LSFG.
To evaluate changes of RFV, the RFV ratio was calcu-
lated as a percentage of the respective baseline value
(100 %), since these are qualitative indices of ‘relative’
blood flow.
Hemodynamics
Within a certain range, the relationship between RFV
and ocular perfusion pressure (OPP) is bilinear in healthy
subjects with normal eyes [8]. To exclude physiological re-
sponses from the present results, the blood pressure and
intraocular pressure (IOP) were measured to calculate the
OPP. Mean blood pressure (MBP) was calculated from the
systolic blood pressure (SBP) and diastolic blood pressure
(DBP) as MBP = DBP + 1/3(SBP −DBP). Then OPP was
calculated by using the following equation: OPP = 2/
3MBP − IOP [9].
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Statistical analysis
All analyses were performed with SAS System 9.3 soft-
ware (SAS Institute Inc., Cary, North Carolina, USA).
Results are presented as the mean ± SD. Student’s t-test
was employed to compare unpaired continuous variables
with a normal distribution. The one sample t-test was
used to assess the hypothesis that a mean value is equal
to 100. Two-tailed p values of less than 0.05 were con-
sidered to indicate a significant difference.
Results
The clinical characteristics of the BRVO patients are
summarized in Table 1. There were 18 men and 17
women aged 67.6 ± 11.0 years (mean ± SD). The mean
duration of macular edema was 53.3 ± 40.4 days (range:
15–180 days). Twenty-three of the 35 patients (66 %)
had hypertension and 15 of the 35 patients (43 %) had
hyperlipidemia.
At the initial examination, the mean BCVA was log
MAR 0.62 ± 0.34, and it improved significantly to log
MAR 0.29 ± 0.27 by 1 month after IVB (p < 0.001)
(Table 1). The initial mean CMT was 634 ± 235 μm and
it decreased significantly to 286 ± 117 μm by 1 month
after IVB (p < 0.001) (Table 1).
The RFV measured with LSFG are summarized in
Table 2. Figure 2 (a-d) shows the RFV ratios in arterial
and venous for the occluded and non-occluded regions.
The RFV measured with LSFG changed from 192 ±
113 AU to 194 ± 112 AU, from 287 ± 144 AU to 280 ±
149 AU, from 208 ± 93 AU to 228 ± 107 AU, and from
355 ± 149 AU to 393 ± 187 AU, respectively (Table 2).
The four RFV ratios were 102.5 %, 97.3 %, 106.1 %, and
110.8 % at 1 month after IVB, respectively (Fig. 2a-d).
There was no significant difference of three ratios (arter-
ial or venous of the occluded region and arterial of the
non-occluded region) at 1 month after IVB (p = 0.586,
p = 0.483, and p = 0.175, respectively) (Fig. 2a-c). However,
the venous RFV ratio of the non-occluded region was sig-
nificantly increased at 1 month after IVB (p = 0.021)
(Fig. 2d).
When the relationship between the RFV ratio and the
severity of retinal ischemia was investigated, 2 subjects
were excluded because assessing the non-perfused area
was difficult due to severe retinal hemorrhage. A significant
Fig. 1 Representative fundus color photograph and representative RFV data obtained with LSFG. a Fundus color photograph shows branch
retinal vein occlusion (BRVO). The upper part is the occluded region and the lower part is the non-occluded region. b Blood flow in an artery
(white square #1) and a vein (white square #2) from the occluded region was automatically tracked in the images. Blood flow in an artery
(white square #3) and a vein (white square #4) from the non-occluded region was also automatically tracked
Noma et al. BMC Ophthalmology  (2016) 16:61 Page 3 of 7
negative correlation was found between the venous
RFV ratio and the severity of retinal ischemia in the oc-
cluded region (r = -0.49, p = 0.003) (Fig. 3b). On the other
hand, there was no significant correlation between the
other RFV ratios and the severity of retinal ischemia (arter-
ial RFV ratio in the occluded region, arterial RFV ratio in
the non-occluded region and venous RFV ratio in the non-
occluded region: r = -0.21, p = 0.228, r = 0.01, p = 0.988, and
r = 0.12, p = 0.481, respectively) (Fig. 3a, c, and d).
When BRVO eyes were divided into ischemic and
non-ischemic group, this study included 14 ischemic
eyes. In the ischemic group, there was a significant de-
crease in the venous RFV ratio of the occluded region
after IVB (83.0 %, p = 0.006). In contrast, the other three
RFV ratios (arterial ratio of the occluded region and
both ratios of the non-occluded region) did not change
significantly after IVB (95.0 %, p = 0.155, 102.6 %, p =
0.478, and 114.3 %, p = 0.474, respectively).
The OPP and ocular hemodynamics were measured in
all eyes before and after IVB. There was no significant
difference of OPP between before IVB (51.1 ± 8.5) and
after IVB (51.2 ± 7.6) (p = 0.930) (Table 1). There was also
no significant correlation between RFV and OPP, indicat-
ing that the observed changes of RFV were not influenced
by the systemic circulation (data not shown). Furthermore,
there were no significant correlations between the dur-
ation of macular edema and the four baseline RFV values
(arterial or venous RFV of the occluded and non-occluded
regions) (r = -0.18, p = 0.298, r = 0.01, p = 0.984, r = -0.10,
p = 0.557, and r = -0.16, p = 0.354, respectively).
Discussion
The present study revealed changes of the RFV in either
the occluded or non-occluded region passing through
the optic disc after IVB in BRVO patients with macular
edema. First, we found that the venous RFV ratio only
increased significantly in the non-occluded region at
1 month after IVB (Fig. 2d). This suggests that an in-
crease of venous outflow in the non-occluded region
removes fluid from the macular region and may influ-
ence the resolution of macular edema after IVB. Alterna-
tively, resolution of macular edema may be primarily
due to reduced vascular leakage because of the effects of
anti-VEGF therapy rather than due to an increase of
venous outflow in the non-occluded region.
Interestingly, we only found a significant negative cor-
relation between the venous RFV ratio and the severity
of retinal ischemia in the occluded region (Fig. 3b), sug-
gesting that the response of venous outflow to IVB may
depend on the severity of retinal ischemia in the occluded
region alone. Generally, retinal ischemia is associated with
capillary loss. Capillaries contribute to the regulation of
blood flow in the retina through contraction or relaxation
of pericytes, which are cells surrounding the capillaries
that are similar to vascular smooth muscle cells [10]. Ac-
cordingly, capillary loss may have led to the significant de-
crease of venous RFV in the occluded region after IVB. In
addition, the level of vascular endothelial growth factor
(VEGF) in the vitreous fluid is correlated with the nonper-
fused retinal area in BRVO patients [11]. VEGF has been
shown to stimulate the production of nitric oxide (NO),
an endothelium-derived relaxing factor [12]. The endothe-
lium of blood vessels releases NO to promote the relax-
ation of vascular smooth muscle, resulting in vasodilation
and increased blood flow [13]. Therefore, a decrease of
VEGF after IVB may lead to vasoconstriction secondary
to reduced production of NO, and this may also have
influenced the significant decrease of the venous RFV
ratio in the occluded region after IVB. Recently, Shimura
et al. reported that macular ischemia occurred after IVB in
patients with central retinal vein occlusion [14]. Based on
our finding that there was a significant negative correl-
ation between the venous RFV ratio and the severity of
retinal ischemia in only the occluded region, it is possible
Table 1 Clinical and demographic data of the BRVO patients
No. (Male/Female) 35 (18/17)
Age (yrs) 67.6 ± 11.0
Hypertension 23 (66 %)
Systolic Blood pressure (mmHg) 131 ± 17
Diastolic Blood pressure (mmHg) 78 ± 16
OPP (mmHg)
Baseline 51.1 ± 8.5
1 month after IVB 51.2 ± 7.6
Hyperlipidemia 15 (43 %)
Duration of BRVO (days) 53.3 ± 40.4
Severity of retinal ischemia (disc area) 26.1 ± 30.1
BCVA (log MAR)
Baseline 0.62 ± 0.34
1 month after IVB 0.29 ± 0.27
CMT (μm)
Baseline 634 ± 235
1 month after IVB 286 ± 117
BRVO branch retinal vein occlusion, No. number of eyes, OPP ocular perfusion
pressure, BCVA best-corrected visual acuity, log MAR logarithm of minimal
angle of resolution, IVB intravitreal injection of bevacizumab, CMT central
macular thickness
Table 2 RFV (arterial and venous) in the occluded and
non-occluded regions
Occluded Region Non-occluded Region
Variable Artery (A.U.) Vein (A.U.) Artery (A.U.) Vein (A.U.)
Baseline 192 ± 113 287 ± 144 208 ± 93 355 ± 149
1 month after IVB 194 ± 112 280 ± 149 228 ± 107 393 ± 187
RFV relative flow volume, IVB intravitreal injection of bevacizumab
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that IVB promoted ischemia by reducing RFV in the
BRVO patients. Therefore, use of IVB in ischemic BRVO
may need careful attention, and measuring RFV by LSFG-
NAVI before treatment may be useful in BRVO patients.
However, further investigations will be needed to clarify
the RFV by using LSFG-NAVI in BRVO patients receiving
treatment for macular edema.
The present study also demonstrated that there was
no significant change of the arterial RFV ratio in either
the occluded or non-occluded region at 1 month after
IVB (Fig. 2a and c), and that there was no significant
correlation between the arterial RFV ratio and the sever-
ity of retinal ischemia in either region (Fig. 3a and c).
These results suggest that IVB does not influence the ar-
terial blood supply of the retina and probably does not
promote retinal ischemia. Autoregulation of retinal blood
flow involves interaction of myogenic and metabolic
mechanisms through the release of vasoactive substances
by the vascular endothelium and retinal tissues surround-
ing the arterioles [15]. Autoregulation adapts the tone of
the resistance vessels (arterioles and capillaries) to changes
of the OPP or tissue metabolic requirements. This adapta-
tion occurs through the interaction of multiple mecha-
nisms affecting the arteriolar smooth muscle cells and
capillary pericytes. Mechanical stretch and an increase of
arteriolar transmural pressure induce the release of con-
tractile factors affecting the tone of arteriolar smooth
muscle cells and pericytes [15]. Nagaoka et al.[16] re-
ported that the retinal arterioles play an important role in
autoregulation of retinal blood flow via a myogenic mech-
anism. Thus, autoregulation of the retinal arterioles may
ensure that there is no change of the arterial RFV ratio
after IVB. In addition, development of macular edema in
BRVO patients has been hypothesized to be caused by
Fig. 2 RFV ratios (arterial (a) and venous (b) in the occluded region or arterial (c) and venous (d) in the non-occluded region). a There was no
significant change of the arterial RFV ratio (102.5 %) in the occluded region at 1 month after IVB (p = 0.586). b There was no significant change of
the venous RFV ratio (97.3 %) in the occluded region at 1 month after IVB (p = 0.483). c There was no significant change of the arterial RFV ratio
(106.1 %) in the non-occluded region at 1 month after IVB (p = 0.175). d The venous RFV ratio (110.8 %) in the non-occluded region showed a
significant increase at 1 month after IVB (p = 0.021)
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fluid flux from the vascular compartment to the tissues
(Starling’s Law) [17, 18] after breakdown of the blood-
retinal barrier. Taken together with the present findings,
such reports suggest that an increase of retinal venous
outflow rather than increased arterial blood supply may be
important for improvement of macular edema by IVB.
The present study had several limitations. One major
drawback was the lack of a control group. Second, this
study demonstrated a significant increase of the venous
RFV ratio in the non-occluded region after IVB, but this
may have been a compensatory response like develop-
ment of collateral vessels in the course of BRVO.
Therefore, it is difficult to conclude that the increase
of RFV in non-occluded veins was due to IVB. Ac-
cordingly, future studies comparing retinal venous
flow in different eyes with BRVO immediately prior to
treatment might provide useful data about the relative
influence of bevacizumab therapy versus the natural
course of the disease.
Conclusions
In BRVO patients, macular edema demonstrated signifi-
cant improvement by 1 month after IVB. The venous
RFV ratio showed a significant increase in the non-
occluded region at 1 month after IVB and there was a
significant negative correlation between this ratio and
the severity of retinal ischemia in the occluded region.
On the other hand, the arterial RFV ratio did not change
significantly in the occluded or non-occluded regions
and there was no significant correlation between the ar-
terial RFV ratio and the severity of retinal ischemia in ei-
ther region. These results suggest the possibility that an
increase of retinal venous outflow after IVB influences
the resolution of macular edema and that the response
Fig. 3 Correlation between the RFV ratio and the severity of retinal ischemia. a No significant correlation between the arterial RFV ratio and the
severity of retinal ischemia in the occluded region (r = -0.21, p = 0.228). b Significant negative correlation between the venous RFV ratio and the
severity of retinal ischemia in the occluded region (r = -0.49, p = 0.003). c No significant correlation between the arterial RFV ratio and the severity
of retinal ischemia in the non-occluded region (r = 0.01, p = 0.988). d No significant correlation between the venous RFV ratio and the severity of
retinal ischemia in the non-occluded region (r = 0.12, p = 0.481)
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of venous outflow to IVB depends on the severity of
retinal ischemia in the occluded region.
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